Cinnabarinic acid is an endogenous metabolite of the tryptophan kynurenine pathway and acts as a selective allosteric agonist of mGlu4 receptors, showing no activity at other mGlu receptor subtypes (mGlu1, mGlu2, mGlu5, mGlu6, mGlu7, and mGlu8). It induces apoptosis and inhibits cAMP formation in a concentration-dependent manner, demonstrating potent and efficacious activity in cultured cerebellar granule cells. It functions as a partial agonist of mGlu4 receptors, increasing [3H]InsP formation by approximately 35% at 100 μM.